On April 25th, 2023, we hosted a seminar entitled "Genetically Engineered Lymphocytes for Cancer Immunotherapy." The seminar took place in the Batlouni Amphitheater and was well-attended by a diverse audience, including students, faculty, and researchers from the field of oncology.
The keynote speaker for the event was Dr. Alain Andrea, a Doctor of Pharmacy who holds a PharmD degree from the Saint-Joseph University of Beirut. Dr. Andrea's seminar provided attendees with valuable insights into the exciting field of cancer immunotherapy, specifically the use of genetically engineered lymphocytes.
During his presentation, Dr. Andrea discussed the potential of modified lymphocytes to treat cancer and improve patient outcomes. He also shared the latest research findings on this topic and answered questions from the audience.
The seminar was a huge success, and attendees left with a better understanding of the potential of genetically engineered lymphocytes for cancer treatment. Our commitment to advancing knowledge in the field of oncology was evident, and the event was a testament to the our ongoing dedication to cutting-edge research.
